University of Western Australia

The evolution and challenges introducing cell based therapies into burn care and scar therapy

The University of Pennsylvania

Genetically engineered immunity for cancer: the development and global regulatory approvals of chimeric antigen receptor (CAR) T cells and what’s coming next

University of Malaya

Expedited regulatory pathways for stem cell-based products in Malaysia: ethical and legal considerations

Duke-NUS Medical School

T cell therapy as a localized modulator of tumor immune environment

Nanyang Technological University Singapore

Endothelial instability predisposes ischemic stroke patients to recurrent vascular events

Development of an injectable cartilage gel using chondrogenic progenitor cells

Virus specific T cells as platform for solid tumor immunotherapy

Softer, faster, better! – Substrate mechanics drives superior somatic cell reprogramming outcomes

Effective & cost-effective, but unaffordable? The future of cell and gene therapy

Biospherix

The patient in the incubator: the cytocentric approach to avoiding suboptimal transients

Kyoto University

ADVA Biotechnology

Bringing immune cell therapies to patients, innovative solutions for CAR T manufacturing, enabling scalability and cost reduction

Foundation for Biomedical Research and Innovation

In process monitoring for mass production of pluripotent stem cells

Making the unproven proven

Commercialization of advanced allogeneic cell therapy product in Korea and beyond

RoosterBio Inc.

Radically simplifying scale-up and clinical translation of hMSCs and extracellular vesicles

ESCO Aster

University of Sydney

The oversight of clinical innovation in a medical marketplace

Expansion of human tumor infiltrating γδ T cells for cancer therapy

Baylor College of Medicine

Engineering off-the-shelf therapeutic T-cells to resist host immune rejection

Regeneus’ novel allogeneic stem cell platform for Osteoarthritis

Regulatory updates on cell and gene therapy products in Singapore

Bioprocessing Technology Institute

Future of transfusion medicine – Human induced pluripotent stem cells derived blood?

Stemcell technologies

Characterization of extracellular vesicles produced by human mesenchymal stromal cells in an improved extracellular vesicle-free medium

University of Sydney

The use of professional disciplinary systems to regulate innovation: lessons from stem cell practice in Australia

University of Tokyo

Stem cell expansion of cord blood graft” vs “bridging support with 3rd party hematopoietic stem/progenitor cells

Establishing the National Cell Therapy Program for process development and clinical manufacturing of cell & gene therapy products in Singapore

Closing the loop: a software hypervisor to direct a structured, data science approach to cell process development

Duke-NUS

Cellular therapy for burns/skin injuries: Laminin-based epidermal keratinocytes culture system in xeno-free and chemically defined condition

Mayo Clinic

The Science of stem cell therapy – parameters affecting dosing and efficacy

Fate Therapeutics

Developing allogeneic cellular immunotherapies with iPSC technology

Singhealth

Long term clinical outcomes of stem cell therapy in cartilage repair: Are we ready for the next step?

Duke-NUS

Cardiovascular progenitors for heart regeneration in preclinical models